Events
Column |
|
2/27 5:00
pm - 7:30 pm. MIT Enterprise Forum of CT.
"Entrepreneurial Start Up: An innovative New Technology
Mobile Business Intelligence Solution." Lawn Club, 193
Whitney Ave., New Haven, CT. more |
|
3/6 3:30
pm - 6:00 pm. Connecticut Venture Group. "Investing in
and Growing Consumer Product Companies". Panel
discussions with reception to follow. Mariott Hotel,
Stamford CT. more |
|
3/19 3:00
pm - 6:00 pm. CURE and Yale OCR Present: Optherion. A BioHaven
Entrepreneurship Seminar. Anlyan Center, Congress Avenue,
New Haven, CT. Reception and networking to follow. more |
|
3/24 12:00
noon - 1:30 pm. UConn OTC Series. "DNA-Guided Medicine:
Commercializing the New Biotechnology for Personalized
Healthcare." Gualberto Ruaño, M.D., Ph.D. President
and Chief Executive Officer, Genomas, Inc. Henry Low Center,
UConn Health Center, Farmington, CT. more |
|
3/25 4:30
pm - 7:30 pm. Connecticut Venture Group: International Trade
Workshop. Bridgeport Holiday Inn, Bridgeport. more |
|
3/26 Connecticut
Innovations Annual Technology Celebration. The Aqua Turf
Club, Southington, CT. more |
|
4/11 8:00
am - 6:30 pm. Healthcare 2008 at the Yale School of
Management. "Whose Healthcare is it Anyway?
Understanding the Patient as a Consumer." Omni Hotel,
New Haven, CT. more |
|
4/16 3:30
pm - 6:00 pm. CURE and Yale OCR Present: The Next Big
Idea - Creating a New Venture. A Special BioHaven
Entrepreneurship Panel with Roger Longman of Windhover
Publications. Reception and networking to follow. Anlyan
Center, Congress Avenue, New Haven, CT. more |
|
4/23 3:00
pm - 6:00 pm. CURE and Yale OCR Present: Vidus Ocular. A BioHaven
Entrepreneurship Seminar. Anlyan Center, Congress Avenue,
New Haven, CT. Reception and networking to follow. more |
|
|
|
Sector
Vital But Needs to Gear for Uncertainty
From
the desk of Paul Pescatello, President and CEO of CURE
One
measure of the strength of Connecticut’s bioscience sector
is its calendar of events. Every year brings numerous
opportunities for CURE members and others to get together
for face-to-face networking and the exchange of ideas in
both formal and informal settings, and 2008 is no exception.
For
the full story |
|
Rib-X
Tells the Story of Its Novel Antibiotics
Mix
of science and business fuels attendance at CURE/Yale
BioHaven Series
Rib-X
Pharmaceuticals, Inc. is focused on the design and
development of novel small-molecule antibiotics for the
treatment of antibiotic-resistant infections. Detailing the
company's story Feb 12 in New Haven, as part of the BioHaven
seminar series presented by CURE and Yale OCR, were Bob
Conerly, vice president and CFO, and Erin Duffy, Ph.D., vice
president, structure based drug design. The team was
introduced by Michelle Bowman of series sponsor
PricewaterhouseCoopers.
For
the full story |
|
Pescatello
Reports on UK Stem Cell Facilities
Last
October, at the invitation of the UK government, a
delegation from Connecticut toured a variety of stem cell
research facilities in the UK. Paul Pescatello, a member of
the delegation, reported January 15 to the Connecticut Stem
Cell Advisory Committee.
For
the full story |
|
Two
New Companies Join UConn's TIP
Two new
companies, Revegen Corp and Escientia Life Sciences, will
join UConn's Technology Incubation Program, which offers
space and services to start-ups. UConn has additional wet
lab openings in Farmington. "This is a great
opportunity for early stage firms that want to leverage
their resources through a relationship with the
university," says Rita Zangari, Executive Program
Director of the program.
For
the full story |
|
CURE
Member News Digest
454
Life Sciences announces new products and
software Achillion
names Olek chief medical officer
Alexion
acquires Oklahoma rights
Applied
Spine names Giordano chief medical officer
Bayer
HealthCare gets FDA approval for RECOTHROM™
Boehringer
Ingelheim completes RE-LY™ enrollment
Bristol-Myers
Squibb names West to board
Carigent
receives NSF grant
Cognate takes
Long Wharf space
CuraGen
names Cassidy CFO
Danbury
Hospital names Dodge for laboratory medicine
GlaxoSmithKline
reports results for Restless Legs drug
Hartford
Hospital establishes Gray Cancer Center
HistoRx names
Gupta CEO
Ipsogen
to provide products to AstraZeneca
Johnson
& Johnson CEO sees annual progress
MannKind
sees inhalable insulin progress
NanoViricides
reports it is on course
Neurogen completes
Phase I obesity study
Pfizer
CEO describes solid 2007
PhRMA
supports CEO Cancer Gold Standard™
Purdue
Pharma reports litigation victory
Raindance
invited to World Economic Forum
Rib-X
reports Phase II trials
Vion
confirms FDA go-ahead on Cloretazine® trial
Webster
Bank names Klaus regional VP
UConn
researchers win equipment funding
Yale
bioengineers target brain tumors
For
the full story |
|